Susan Doleman
Technik-/Wissenschafts-/F&E-Leiter bei CYTEIR THERAPEUTICS, INC.
Profil
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
Aktive Positionen von Susan Doleman
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Ehemalige bekannte Positionen von Susan Doleman
| Unternehmen | Position | Ende |
|---|---|---|
| EPIZYME, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Children's Hospital Corp.
 The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| REPLIMUNE GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Susan Doleman
| Smith College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Health Services |
